ArticleiScience2023

DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis.

Boya Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.